Evidence map›Paper›PMID 33859757›Full record

ArticleTheranostics2021

Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension.

Li-Jyuan Luo, Duc Dung Nguyen, Jui-Yang Lai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Li-Jyuan LuoGraduate Institute of Biomedical Engineering, Chang Gung University, Taoyuan 33302, Taiwan.
Duc Dung NguyenGraduate Institute of Biomedical Engineering, Chang Gung University, Taoyuan 33302, Taiwan.
Jui-Yang LaiGraduate Institute of Biomedical Engineering, Chang Gung University, Taoyuan 33302, Taiwan.
Chang Gung University · TWMing Chi University of Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmidesAnimalsCell LineDelayed-Action PreparationsDisease Models, AnimalDrug CarriersDrug Delivery SystemsDrug LiberationEyeGlaucomaHumansNanoparticlesNitroimidazolesOcular HypertensionOphthalmic SolutionsPhotoreceptor Cells1-(2-hydroxy-3-methyoxypropyl)-2-chloro-4-nitroimidazoleAmidesDelayed-Action PreparationsDrug CarriersNitroimidazolesOphthalmic SolutionsPyridinesY 27632ceria nanostructurehollow carrier systemocular therapeuticsshell thicknessY-27632

Identifiers

PMID33859757
PMCPMC8039939
OpenAlexW3138805106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.